HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oscar Palomares Selected Research

Oscar Palomares Research Topics

Disease

27Asthma (Bronchial Asthma)
07/2023 - 07/2006
27Hypersensitivity (Allergy)
01/2023 - 05/2002
9Inflammation (Inflammations)
01/2023 - 06/2012
6Allergic Rhinitis
01/2022 - 01/2017
6COVID-19
01/2022 - 01/2020
5Anaphylaxis (Anaphylactic Shock)
03/2024 - 01/2020
5Chronic Urticaria
01/2023 - 01/2021
5Atopic Dermatitis (Atopic Eczema)
01/2023 - 05/2019
5Infections
01/2022 - 01/2018
4Autoimmune Diseases (Autoimmune Disease)
11/2022 - 03/2011
3Neoplasms (Cancer)
12/2023 - 03/2011
3Food Hypersensitivity (Food Allergy)
01/2023 - 05/2019
3Nasal Polyps (Nasal Polyp)
01/2023 - 05/2019
3Communicable Diseases (Infectious Diseases)
01/2022 - 01/2016
3Seasonal Allergic Rhinitis (Hay Fever)
07/2006 - 01/2006
2Peanut Hypersensitivity (Peanut Allergy)
03/2024 - 01/2022
2Rhinosinusitis
01/2023 - 05/2019
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 01/2018
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2019
2Persistent Infection
06/2012 - 03/2011
1Prurigo
01/2023
1Venom Hypersensitivity
01/2022
1Sepsis (Septicemia)
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Leukemia
01/2021
1Lymphoma (Lymphomas)
01/2021
1Pruritus (Itching)
01/2021
1Urticaria (Hives)
01/2021
1Rhinitis
12/2020
1Chronic Disease (Chronic Diseases)
12/2020
1Cytokine Release Syndrome
11/2020
1Eosinophilia
01/2020
1Coinfection
01/2020
1Allergic Bronchopulmonary Aspergillosis
05/2019
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
05/2019
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2019

Drug/Important Bio-Agent (IBA)

18AllergensIBA
03/2024 - 02/2003
13Immunoglobulin E (IgE)IBA
03/2024 - 07/2006
9VaccinesIBA
01/2023 - 01/2016
7CannabinoidsIBA
07/2023 - 01/2018
7CytokinesIBA
07/2021 - 06/2012
6Omalizumab (Xolair)FDA Link
01/2022 - 05/2019
5dupilumabIBA
01/2021 - 01/2020
4Monoclonal AntibodiesIBA
01/2020 - 05/2007
3MannansIBA
03/2024 - 02/2016
3COVID-19 VaccinesIBA
01/2022 - 01/2021
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2016
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 01/2018
3Glucan 1,3-beta-GlucosidaseIBA
07/2006 - 02/2003
2Prostaglandin D2IBA
01/2022 - 09/2018
2EicosanoidsIBA
01/2022 - 01/2021
2Transcription Factors (Transcription Factor)IBA
07/2021 - 01/2017
2LipidsIBA
01/2021 - 09/2018
2Messenger RNA (mRNA)IBA
01/2021 - 01/2018
2prostaglandin D2 receptorIBA
01/2021 - 09/2018
2AntibodiesIBA
12/2020 - 05/2010
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2020 - 01/2020
2benralizumabIBA
01/2020 - 01/2020
2InterferonsIBA
01/2018 - 01/2017
2AllergoidsIBA
08/2017 - 02/2016
2Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2002
1CarbohydratesIBA
12/2023
1GlycosaminoglycansIBA
12/2023
1Heparitin Sulfate (Heparan Sulfate)IBA
12/2023
1Proteoglycans (Proteoglycan)IBA
12/2023
1antineoplaston A10 (A 10)IBA
12/2023
1anti-IgE antibodiesIBA
11/2022
1Immunoglobulins (Immunoglobulin)IBA
11/2022
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022
1AntipyreticsIBA
01/2022
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1VenomsIBA
11/2021
1Leukotriene Receptors (Leukotriene Receptor)IBA
01/2021
1ProstaglandinsIBA
01/2021
1ThromboxanesIBA
01/2021
1LeukotrienesIBA
01/2021
1LipoxinsIBA
01/2021
1Interleukin-9 (Interleukin 9)IBA
01/2020
1Interleukin-5 (Interleukin 5)IBA
01/2020
1insulin receptor-related receptor (IRR)IBA
01/2020
1mepolizumabIBA
01/2020
1AntigensIBA
01/2020
1reslizumabIBA
01/2020
1cyclopropapyrroloindoleIBA
01/2019
1CystatinsIBA
01/2019
1TabletsIBA
01/2019

Therapy/Procedure

14Therapeutics
07/2023 - 03/2011
5Immunotherapy
01/2022 - 07/2006
2Precision Medicine
01/2020 - 11/2019
2Drug Therapy (Chemotherapy)
01/2019 - 01/2019
2Tonsillectomy
01/2018 - 01/2017
2Organ Transplantation
06/2012 - 03/2011
1Injections
10/2021
1Contraindications
01/2021
1Aftercare (After-Treatment)
01/2021
1Transplantation
01/2021
1Biological Therapy
01/2019